UTAA06 Injection for Treatment of Advanced Malignant Solid Tumors

Clinical trial NCT06372236 · COMPLETED

Trial details

NCT number: NCT06372236
Sponsor: Peking University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Conditions or Focus of Study: B7-H3 Positive Relapsed/Advanced Malignant Solid Tumor

Start date: 2023-12-05
Primary completion: 2025-05-08
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.